Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Am J Ophthalmol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    October 2018
  1. DANNI R, Taipale C, Ilveskoski L, Tuuminen R, et al
    Diabetes alone does not impair recovery from uneventful cataract surgery.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30572.
    PubMed     Text format     Abstract available


  2. PARRAVANO M, De Geronimo D, Scarinci F, Virgili G, et al
    Progression of diabetic microaneurysms according to the internal reflectivity on structural OCT and visibility on OCT angiography.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30573.
    PubMed     Text format     Abstract available


  3. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 6. pii: S0002-9394(18)30504.
    PubMed     Text format    


  4. CHOWDHARY N, Shrivastav A, Koundanya VV, Mayor R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 5. pii: S0002-9394(18)30503.
    PubMed     Text format    


    September 2018
  5. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 29. pii: S0002-9394(18)30490.
    PubMed     Text format    


  6. CALUGARU D, Calugaru M
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 27. pii: S0002-9394(18)30489.
    PubMed     Text format    


  7. KIM K, Kim ES, Yu SY
    Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes.
    Am J Ophthalmol. 2018 Sep 6. pii: S0002-9394(18)30515.
    PubMed     Text format     Abstract available


    August 2018
  8. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 27. pii: S0002-9394(18)30411.
    PubMed     Text format    


  9. OLI A, Balakrishnan D
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 25. pii: S0002-9394(18)30410.
    PubMed     Text format    


  10. MORA N, Kempen JH, Sobrin L
    Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden.
    Am J Ophthalmol. 2018 Aug 20. pii: S0002-9394(18)30473.
    PubMed     Text format     Abstract available


  11. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Aug 8. pii: S0002-9394(18)30444.
    PubMed     Text format     Abstract available


  12. BRESSLER NM, Beaulieu WT, Maguire MG, Glassman AR, et al
    Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T.
    Am J Ophthalmol. 2018 Aug 2. pii: S0002-9394(18)30413.
    PubMed     Text format     Abstract available


    July 2018
  13. CHEN T, Zhu W, Tang B, Jin L, et al
    A Mobile Phone Informational Reminder to Improve Eyecare Adherence among Diabetic Patient in Rural China: A Randomized Controlled Trial.
    Am J Ophthalmol. 2018 Jul 24. pii: S0002-9394(18)30387.
    PubMed     Text format     Abstract available


    June 2018
  14. CALUGARU D, Calugaru M
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Jun 30. pii: S0002-9394(18)30293.
    PubMed     Text format    


    May 2018
  15. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 May 25. pii: S0002-9394(18)30236.
    PubMed     Text format     Abstract available


    April 2018
  16. HOLEKAMP NM, Campbell J, Almony A, Ingraham H, et al
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Apr 20. pii: S0002-9394(18)30170.
    PubMed     Text format     Abstract available


  17. YU CG, Yuan SS, Yang LY, Ke J, et al
    Angiopoietin-like 3 is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
    Am J Ophthalmol. 2018 Apr 2. pii: S0002-9394(18)30155.
    PubMed     Text format     Abstract available


    March 2018
  18. SEPAHI S, Mohajeri SA, Hosseini SM, Khodaverdi E, et al
    Effects of crocin on diabetic maculopathy; a placebo controlled randomized clinical trial.
    Am J Ophthalmol. 2018 Mar 14. pii: S0002-9394(18)30105.
    PubMed     Text format     Abstract available


    February 2018
  19. HOU H, Shoji T, Zangwill LM, Moghimi S, et al
    Progression of Primary Open Angle Glaucoma in Diabetic and Non-diabetic Patients.
    Am J Ophthalmol. 2018 Feb 12. pii: S0002-9394(18)30051.
    PubMed     Text format     Abstract available


    January 2018
  20. CASTILLO J, Aleman I, Rush SW, Rush RB, et al
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30537.
    PubMed     Text format    


  21. OLI A, Balakrishnan D, Rani PK
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30538.
    PubMed     Text format    


  22. ZHANG XZ, Tu WJ, Wang H, Zhao Q, et al
    Circulating serum fatty acid binding protein 4 levels predict the development of the diabetic retinopathy in type 2 diabetic patients.
    Am J Ophthalmol. 2018 Jan 2. pii: S0002-9394(17)30560.
    PubMed     Text format     Abstract available


    December 2017
  23. GOWER EW, Lovato JF, Ambrosius WT, Chew EY, et al
    Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study.
    Am J Ophthalmol. 2017 Dec 21. pii: S0002-9394(17)30536.
    PubMed     Text format     Abstract available


  24. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 9. pii: S0002-9394(17)30470.
    PubMed     Text format    


  25. CALUGARU D, Calugaru M
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 5. pii: S0002-9394(17)30474.
    PubMed     Text format    


    October 2017
  26. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early response to intravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome.
    Am J Ophthalmol. 2017 Oct 12. pii: S0002-9394(17)30427.
    PubMed     Text format     Abstract available


  27. WANG JC, Lains I, Providencia J, Armstrong GW, et al
    Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy with Swept-Source Optical Coherence Tomography.
    Am J Ophthalmol. 2017 Oct 5. pii: S0002-9394(17)30422.
    PubMed     Text format     Abstract available


  28. JOHNSON CA, Thapa S, George Kong YX, Robin AL, et al
    Performance of an iPad Application to Detect Moderate and Advanced Visual Field Loss in Nepal.
    Am J Ophthalmol. 2017;182:147-154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: